DARWIN Biomed, a deep tech company specialising in advanced robotics applied to healthcare, has closed a €1 million Pre-Seed funding round to accelerate the development and clinical validation of its technology aimed at improving people’s quality of life.
The round was structured in two investment phases, strategically aligned with the regulatory and validation requirements of the sector. In the first phase, Easo Ventures and ERREKA made the initial investment, enabling the project to launch and advance its early-stage technological development. In the second phase, Sodena and several business angels joined the round, and together with the additional support of Adrián Jiménez Loygorri and Easo Ventures, consolidated the successful closing of the financing.
In addition to the direct equity investment, the transaction was complemented by public and bank financing, including a participative loan from ENISA and bank financing aimed at strengthening the company’s financial structure at this early growth stage.
DARWIN Biomed is currently developing MICHELANGELO, an intelligent walker based on assistive robotics and advanced intelligence, designed to improve people’s autonomy, safety and quality of life.
The project aims to become a benchmark in technology transfer from the deep tech field into real-world solutions for society, integrating advanced robotics with a human-centred approach to solving everyday challenges associated with ageing and mobility.
The funds raised will enable the company to advance in three key strategic areas:
The company currently has a team of four people (three founding partners and one employee) and expects to double its workforce over the next 18 months. Within that same timeframe, DARWIN Biomed expects to achieve decisive growth milestones, including obtaining both CE and FDA regulatory approvals and launching the commercialisation of its technology in the European Union (EU-27) and the United States.
According to Adrián Jiménez Loygorri, CEO of DARWIN Biomed: “We work every day to lead from Navarra the international adoption of cutting-edge robotics solutions.”
The participation of Easo Ventures and ERREKA as lead investors brings to the project a combination of expertise in technology venture capital and industrial capabilities, while Sodena and the business angels strengthen the financial and strategic backing needed to drive the company’s early-stage growth.
From Sodena, they highlighted the project’s value within the regional innovation ecosystem: “DARWIN Biomed represents the type of technological initiative we aim to support in Navarra: deep tech projects with high growth potential, international impact, and the ability to generate knowledge and skilled employment.”
This transaction positions DARWIN Biomed as one of the emerging deep tech startups in advanced robotics in Europe, within an increasingly dynamic ecosystem driven by collaboration between industry, venture capital and public institutions.
About DARWIN Biomed
DARWIN Biomed is a deep tech company focused on developing advanced robotics technologies applied to healthcare, longevity and quality of life improvement. The company develops assistive robotics solutions powered by advanced intelligence to improve people’s autonomy, safety and wellbeing.
About Easo Ventures
Easo Ventures is a venture capital firm based in San Sebastián, established in 2018 and managed by Stellum Capital, investing in startups and innovative companies at early stages (Pre-Seed to Series A). It has more than 100 investors — companies, entrepreneurs and executives from the Basque Country — who provide not only capital but also expertise and experience to portfolio companies. Since its foundation, Easo Ventures has raised two funds and invested in more than 80 companies across sectors including artificial intelligence, industry, healthcare, cybersecurity and software.
About ERREKA
ERREKA is a cooperative within Mondragon Corporation, founded 65 years ago, employing more than 500 people and generating revenues of over €75 million. It specialises in developing and manufacturing advanced technological solutions for a range of industrial sectors, including applications for healthcare.
About Sodena
Sodena is the financial instrument of the Government of Navarra for attracting and developing high value-added business projects that contribute to local anchoring, economic growth and quality employment generation in the region. Its work focuses on financially supporting companies, accompanying them in their implementation and expansion, facilitating their integration into Navarra’s business ecosystem, and providing access to an extensive network of contacts.
In addition, this public entity coordinates the design and execution of Navarra’s S4 Smart Specialisation Strategy, aligning economic activity with the region’s priority sectors. Sustainability is embedded across all of its activities, promoting the transition towards a circular and responsible economy.
Currently, Sodena holds stakes in around 90 companies that generate more than 4,500 jobs in Navarra, backed by a total investment of €160 million. The entity applies responsible investment and sustainability criteria across all its operations, is a signatory of the United Nations Principles for Responsible Investment (UNPRI), and is a member of the United Nations Global Compact.
Caption: Jesús Cornago, Amaya Álvarez, Alberto Estella and Adrián Jiménez
cloud technology axon
Xcalibur Smart Mapping, recognised as the global leader in airborne...
